Gilead Sciences, Inc.GILDNASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank79
3Y CAGR+9.5%
5Y CAGR+11.8%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+9.5%/yr
vs +1.9%/yr prior
5Y CAGR
+11.8%/yr
Consistent
Acceleration
+7.6pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.19 | +29.5% |
| 2024 | 4.01 | +7.4% |
| 2023 | 3.73 | -5.6% |
| 2022 | 3.95 | +18.2% |
| 2021 | 3.34 | +12.6% |
| 2020 | 2.97 | -19.3% |
| 2019 | 3.68 | +0.2% |
| 2018 | 3.67 | +2.3% |
| 2017 | 3.59 | +13.7% |
| 2016 | 3.16 | - |